Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / JAZZ - Jazz Pharmaceuticals EPS beats by $0.45 beats on revenue


JAZZ - Jazz Pharmaceuticals EPS beats by $0.45 beats on revenue

Jazz Pharmaceuticals (NASDAQ:JAZZ): Q2 Non-GAAP EPS of $3.90 beats by $0.45; GAAP EPS of -$6.11 misses by $2.81. Revenue of $751.8M (+33.7% Y/Y) beats by $14.5M. Re-affirms prior revenue guidance of $3.02B-$3.18B vs. $3.11B consensus. Re-affirms prior Non-GAAP EPS of $13.40-$14.70 vs. $14.42 consensus. Shares +1%. Press Release

For further details see:

Jazz Pharmaceuticals EPS beats by $0.45, beats on revenue
Stock Information

Company Name: Jazz Pharmaceuticals plc
Stock Symbol: JAZZ
Market: NASDAQ
Website: jazzpharmaceuticals.com

Menu

JAZZ JAZZ Quote JAZZ Short JAZZ News JAZZ Articles JAZZ Message Board
Get JAZZ Alerts

News, Short Squeeze, Breakout and More Instantly...